Fig. 1.
Fig. 1. Treatment outcomes of patients with PRCA associated with T-LDGL from diagnosis until first response. / CR indicates complete response; PR, partial response; NR, no response; DNT, did not tolerate; CHOP, cyclophosphamide/doxorubicin/vincristine/prednisone; CVP, cyclophosphamide/vincristine/prednisone; pt, patient.

Treatment outcomes of patients with PRCA associated with T-LDGL from diagnosis until first response.

CR indicates complete response; PR, partial response; NR, no response; DNT, did not tolerate; CHOP, cyclophosphamide/doxorubicin/vincristine/prednisone; CVP, cyclophosphamide/vincristine/prednisone; pt, patient.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal